Wed, March 12, 2025
Tue, March 11, 2025
Mon, March 10, 2025

$30 Million Grant Supports AI-Powered Antibody Therapy Development

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. rts-ai-powered-antibody-therapy-development.html
  Print publication without navigation Published in Science and Technology on by AZoLifeSciences
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.
The article from MSN discusses a significant $30 million grant awarded to the University of California, San Francisco (UCSF) to advance the development of AI-powered antibody therapies. This funding, provided by the National Institute of Allergy and Infectious Diseases (NIAID), aims to accelerate the discovery and optimization of antibodies for treating infectious diseases. The project leverages AI and machine learning to analyze vast datasets, predicting how antibodies will interact with pathogens, thereby speeding up the process from discovery to clinical trials. This initiative not only focuses on enhancing the speed of antibody development but also on improving their effectiveness and safety, potentially transforming how we respond to future pandemics and other infectious threats.

Read the Full AZoLifeSciences Article at:
[ https://www.msn.com/en-gb/science/biology/30-million-grant-supports-ai-powered-antibody-therapy-development/ar-AA1AEFSc ]